Policy | May 11, 2026
Dr. Jitendra Singh calls for stronger research ecosystem
The Union Minister reviewed DST-supported SATHI-BHU facility
The Union Minister reviewed DST-supported SATHI-BHU facility
The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy
Q2 2026 analysis shows expanding approvals, stronger uptake, and a shift toward evidence-driven biosimilar evaluation
The agreements aim to strengthen medicine quality, patient safety and pharmaceutical research in India
Veteran pharma leader brings 33+ years of experience to drive operational excellence in formulation business
Neuland Laboratories reported an uptick in peptide-related engagements from Japanese companies, particularly at the preclinical and early clinical stages
Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials
Shift from approvals to digital intimation via NSWS portal aims to cut timelines and boost innovation in early-stage drug development
Experts highlighted that robust pharmacopoeial frameworks are essential for maintaining the quality, safety and efficacy of medicines
Hyderabad-based peptide specialist strengthens complex generics credentials as Apotex prepares for U.S. commercialization of semaglutide injection
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
